Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels
- PMID: 24360992
- PMCID: PMC3962701
- DOI: 10.1016/j.jpeds.2013.10.071
Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels
Abstract
Objective: To investigate the histological spectrum of nonalcoholic fatty liver disease (NAFLD) in children with normal, mildly elevated (26-50 U/L boys, 23-44 U/L girls), or elevated (>50 U/L in boys, >44 U/L in girls) serum alanine aminotransferase (ALT) levels.
Study design: The Nonalcoholic Steatohepatitis Clinical Research Network enrolls children aged 5-18 years with NAFLD. We analyzed baseline clinical and histological data from 91 children with suspected NAFLD and normal or mildly elevated ALT and liver biopsy analysis within 180 days of ALT measurement, and compared them with data from 392 children with elevated ALT.
Results: Seventeen of the 91 children with suspected NAFLD (19%) had a normal ALT level, and 74 (81%) had a mildly elevated ALT level. Overall, 45% of the biopsy specimens analyzed had steatosis ≥33%, 22% had grade ≥2 lobular inflammation, 81% had portal inflammation, 29% had ballooned hepatocytes, 35% had "suspicious/borderline" steatohepatitis, 8% had definite nonalcoholic steatohepatitis, 34% had an NAFLD activity score ≥4, and 46% had fibrosis (38% mild/moderate and 8% bridging/cirrhosis). Marked steatosis (50% vs 24%) and fibrosis (54% vs 12%) were significantly more common in the patients with mildly elevated ALT compared with those with normal ALT, with no difference in ballooning, inflammation, or NAFLD activity score ≥4 between the 2 groups. Fibrosis stage 3/4 was seen in none of the children with normal ALT, in 9% of those with mildly elevated ALT, and in 15% of those with elevated ALT.
Conclusion: Liver biopsy specimens from children with NAFLD with normal or mildly elevated ALT levels show significant histological abnormalities, including advanced fibrosis in children with mildly elevated ALT. Thus, measurement of ALT may underestimate liver injury in NAFLD. The use of appropriate ALT cutoff levels can help identify children at risk for more severe disease.
Trial registration: ClinicalTrials.gov NCT01061684.
Copyright © 2014 Mosby, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Comment in
-
There's more under the nonalcoholic fatty liver disease umbrella than an elevated alanine aminotransferase level.J Pediatr. 2014 Apr;164(4):684-6. doi: 10.1016/j.jpeds.2013.12.026. Epub 2014 Jan 23. J Pediatr. 2014. PMID: 24461787 No abstract available.
References
-
- Alisi A, Manco M, Vania A, Nobili V. Pediatric Nonalcoholic Fatty Liver Disease in 2009. J Pediatr. 2009;155:469–474. - PubMed
-
- Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis. 2004;8:549–558. - PubMed
-
- Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120:S164–S192. - PubMed
-
- Strauss RS, Barlow SE, Dietz WH. Prevelance of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136:727–733. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01DK061731/DK/NIDDK NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- U01DK061737/DK/NIDDK NIH HHS/United States
- U01 DK061731/DK/NIDDK NIH HHS/United States
- U01 DK061718/DK/NIDDK NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- U01 DK061730/DK/NIDDK NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- UL1 RR025014/RR/NCRR NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- U01DK061738/DK/NIDDK NIH HHS/United States
- U01DK061730/DK/NIDDK NIH HHS/United States
- U01 DK061737/DK/NIDDK NIH HHS/United States
- U01 DK061713/DK/NIDDK NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- U01DK061713/DK/NIDDK NIH HHS/United States
- UL1 RR025761/RR/NCRR NIH HHS/United States
- UL1RR24156/RR/NCRR NIH HHS/United States
- UL1RR029887/RR/NCRR NIH HHS/United States
- U01 DK061732/DK/NIDDK NIH HHS/United States
- UL1RR025741/RR/NCRR NIH HHS/United States
- UL1RR025761/RR/NCRR NIH HHS/United States
- M01 RR000188/RR/NCRR NIH HHS/United States
- UL1 RR025741/RR/NCRR NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01DK061718/DK/NIDDK NIH HHS/United States
- UL1RR031990/RR/NCRR NIH HHS/United States
- UL1RR025055/RR/NCRR NIH HHS/United States
- U01DK061732/DK/NIDDK NIH HHS/United States
- U01DK061728/DK/NIDDK NIH HHS/United States
- UL1 RR031990/RR/NCRR NIH HHS/United States
- U01 DK061728/DK/NIDDK NIH HHS/United States
- UL1RR025014/RR/NCRR NIH HHS/United States
- U01 DK061738/DK/NIDDK NIH HHS/United States
- UL1RR024989/RR/NCRR NIH HHS/United States
- UL1RR024131/RR/NCRR NIH HHS/United States
- U01 DK061734/DK/NIDDK NIH HHS/United States
- UL1 RR031980/RR/NCRR NIH HHS/United States
- UL1RR031980/RR/NCRR NIH HHS/United States
- UL1 RR029887/RR/NCRR NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- M01RR00188/RR/NCRR NIH HHS/United States
- U01DK061734/DK/NIDDK NIH HHS/United States
- S10 RR025055/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
